Wujiu Jiang

Dr. Wujiu Jiang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of Molecular Structure
Verified
Journal Article
Closed access
YTYu-Xing Tan
Yu-Xing Tan
ZZZhi-Jian Zhang
Zhi-Jian Zhang
YLYang Liu
Yang Liu
JYJiang-Xi Yu
Jiang-Xi Yu
XZXiao-Ming Zhu
Xiao-Ming Zhu
WJWujiu Jiang
Wujiu Jiang

31 March 2022 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
WJWujiu Jiang
Wujiu Jiang
QQQiqi Qin
Qiqi Qin
XXXiyuan Xiao
Xiyuan Xiao
YTYu-Xing Tan
Yu-Xing Tan

1 January 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
WJWujiu Jiang
Wujiu Jiang
SFShanji Fan
Shanji Fan
QZQian Zhou
Qian Zhou
FZFuxing Zhang
Fuxing Zhang
DKDaizhi Kuang
Daizhi Kuang
YTYu-Xing Tan
Yu-Xing Tan

3 October 2018 in Inorganic and Nano-Metal Chemistry
Verified
Journal Article
Closed access
ZZZhi-Jian Zhang
Zhi-Jian Zhang
HZHui-Ting Zeng
Hui-Ting Zeng
YLYang Liu
Yang Liu
DKDai-Zhi Kuang
Dai-Zhi Kuang
FZFu-Xing Zhang
Fu-Xing Zhang
WJWujiu Jiang
Wujiu Jiang
Schiff base butyltin complexes C1 ∼ C3 have been synthesized via the reaction of dibutyltin oxide with the substituted salicylaldehyde-o-aminophenol Schiff base ligands (L1 ∼ L3), respectively. The complexes have been characterized by elemental analysis, IR, UV-Vis, 1H NMR, 13C NMR spectra and the crystal structures have been determined by X-ray diffraction. The anticancer activity of the Schiff base ligands L1 ∼ L3 and complexes C1 ∼ C3 against five species of cancer cells which are MCF7, Colo205, NCI-H460, Hela and HepG2 were tested respectively, the tests showed that C3 exhibited significant anticancer activity for the cancer cells in comparison with other complexes. The interaction between C3 and calf thymus DNA were studied by fluorescence, UV-Vis and Viscosity experiment, the results show that the interaction of C3 with calf thymus DNA was intercalation.

30 March 2022 in Metallomics
Verified
Journal Article
Closed access
PDF file
WJWujiu Jiang
Wujiu Jiang
ZZZhijian Zhang
Zhijian Zhang
PNPenghui Ni
Penghui Ni
YTYu-Xing Tan
Yu-Xing Tan
Fourteen new organotin(IV) complexes were successfully synthesized and characterized by elemental analyses, Fourier transform infrared spectroscopy (FT-IR), multinuclear (1H, 13C, and 119Sn) NMR spectroscopy, high-resolution mass spectrometry (HRMS), and X-ray single-crystal techniques. Crystallographic data showed that the complexes 1b, 2b, 3b, and 5b were macrocyclic compounds, 4b exhibited a one-dimensional spiral chain structure with distorted trigonal bipyramidal geometry, other complexes were centrosymmetric dimers, and there was an Sn2O2 four-membered ring in the middle of the molecule. In-vitro anticancer activity against the three human tumor cell lines NCI-H460, MCF-7, and HepG2 was studied, and the dibutyltin complex 5a is a more potent antitumor agent than other complexes and cisplatin. Cell apoptosis study of 5a with the highest activity on HepG2 cancer cell lines was done by flow cytometry; it was shown that the antitumor activity of 5a was related to apoptosis, and it inhibited proliferation by blocking cells in the G2/M phase. The single-cell gel electrophoresis assay results show that 5a induces DNA damage. 5a interacts with ct-DNA by intercalating the mode of interaction. UV–visible absorption spectrometry, fluorescence competitive, viscosity measurements, and gel electrophoresis results also support the intercalative mode of interaction for 5a with DNA.

30 November 2016 in Journal of Inorganic and Organometallic Polymers and Materials
Verified
Journal Article
Closed access
PDF file
YTYu-Xing Tan
Yu-Xing Tan
ZZZhi-Jian Zhang
Zhi-Jian Zhang
YFYong-Lan Feng
Yong-Lan Feng
JYJiang-Xi Yu
Jiang-Xi Yu
XZXiao-Ming Zhu
Xiao-Ming Zhu
WJWujiu Jiang
Wujiu Jiang